Flutemetamol MR PET study
ICH case-case comparison of Flutemetamol binding
This is an investigator-sponsored study, partly funded by GE Healthcare. The pathophysiological hypotheses to be tested are:
-
Primary: The amount and distribution of 18F-flutemetamol uptake will differ between cases with:
- lobar ICH probably related to CAA, according to the modified Boston criteria9
- lobar ICH possibly related to CAA, according to the modified Boston criteria9
- deep ICH (neither probably or possibly related to CAA, according to the modified Boston criteria9)
- Secondary:
- To correlate the distribution of 18F-flutemetamol retention with magnetic resonance imaging (MRI) features associated with CAA (small foci of haemorrhage near the surface of the brain (lobar microbleeds) for example) and retinal imaging biomarkers.